// App-Quantinova.ai

e17057 : PD-1, PD-L1 in BRCA1/2-mutated and non-mutated epithelial ovarian carcinomas (EOCs).

Researchers

Presenter

  • Jasgit C. Sachdev

Principal Investigators

  • David Arguello

  • Brian L. Abbott

  • Sandeep K. Reddy

Medical Centers

  • Scottsdale Healthcare, Paradise Valley, AZ

  • Caris Life Sciences, Phoenix, AZ

  • Caris Life Sciences, Great Falls, MT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved